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Sites of first distant recurrence in resected non- 
small-cell lung cancer 
To the Editor: 
I read with interest the article by Yano and associates, t 
The authors hypothesize that the venous drainage of 
mediastinal lymph nodes is to the superior vena cava and 
that this may increase the likelihood of pulmonary metas- 
tasis in patients with N2 lung cancer. This proposed 
mechanism of metastatic spread is not present in patients 
with NO lung cancer; therefore a different pattern of 
distant failure is anticipated in such patients. The hypoth- 
esis is fascinating, but the authors' data are insufficient to 
justify its acceptance. 
The lung was the first site of distant recurrence in 10 of 
52 patients with NO disease and 12 of 40 with N2 disease. 
Although my knowledge of statistics i limited, a simple X z 
test to compare the frequency of lung metastasis n the 
two groups would appear to be appropriate. This test gives 
a p value of 0.23 (X z = 1.44). The authors state that the 
overall pattern of distant metastasis was different between 
patients with NO disease and those with N2 disease (p = 
0.044). Although their statement is undoubtedly true, the 
difference isprobably a reflection of the higher incidence of 
brain metastasis in the NO group (p < 0.013, X z = 6.14). A 
significant difference in the prevalence of brain metastasis 
does not necessarily support the authors' hypothesis of 
pulmonary metastatic spread from mediastinal lymph nodes. 
John D. Urschel, MD, FRCSC 
Division of Thoracic Surgery 
Roswell Park Cancer Institute 
Elm and Carlton Streets 
Buffalo, NY 14263-0001 
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Early production of interleukin-10 during 
normothermic ardiopulmonary bypass 
To the Editor: 
Cardiopulmonary bypass (CPB) is known to cause a 
systemic inflammatory response associated with an in- 
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Fig. 1. For definition of times T and H, see text. 
leukin-1 [IL-1], IL-6, and IL-8). 1' 2 Several studies uggc 
that IL-10 is an important factor in the down-regulation 
inflammatory esponses, in particular by inhibiting in vit 
proinflammatory c tokine synthesis by neutrophils (PMI 
and monocytes. 3 We hypothesized that IL-10 might 1 
produced during CPB and could represent a regulato 
mechanism controlling monocyte/PMN activation in vi~ 
We therefore measured plasma levels of IL-10 in comp~ 
ison with that of IL-6 and IL-8 in patients undergoi~ 
cardiac operations with normothermic CPB. 
Eight patients, 47.8 _+ 8.9 years of age (mean 
standard error of the mean), were studied. Patients wi 
corticosteroid therapy or suspected infectious diseas 
were excluded. Anesthesia nd CPB management we 
performed as previously described) Mean CPB and aorl 
clamping durations were 115 --- 9 and 89 + 8 minut~ 
respectively (mean --- standard error of the mean). SerJ 
blood samples were withdrawn from the radial arte 
catheter before sternotomy (TO), at the onset of Ct 
(H0), and at intervals of 1, 2, 4, 6, 10, and 24 hours (HI 
H24) after the onset of CPB. Blood samples were cc 
lected into sterile vacuum tubes with ethylenediaminet~ 
raacetic acid, immediately centrifuged, and stored 
-70~ We measured IL-10 using an enzyme-linkq 
immunosorbent assay that is specific for human IL- 
(EASIA Medgenix, Fleurus, Belgium) and IL-6 and II_ 
by enzyme-linked immunosorbent assays from Amersha 
(Biotrak, les Ulis, France). 
As shown in Fig. 1, whereas IL-10 was undetectable 
any of the plasma samples at TO and H0, plasma IL- 
levels rose in all of the patients as early as 1 hour after t] 
onset of CPB, peaked either at H1 or H2 (HI, 76.2 +- 2~ 
pg/ml; H2, 73.5 + 24.8 pg/ml; mean _+ standard error 
the mean; p = 0.01 versus H0 by Wilcoxon's matche 
paired test), and decreased at H4 (23.6 _+ 10 pg/ml). II_ 
and IL-8 levels peaked at 4 and 2 hours, respectively, aft 
the onset of CPB. By contrast with the strong positi 
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correlation observed between plasma IL-6 and IL-8 con- 
centrations (p = 0.91; p - 0.02, Spearman rank order 
test), the level of IL-10 production was unrelated to the 
levels of IL-8 and IL-6. 
Our results how that CPB causes the rapid and transient 
release of IL-10. The differences in kinetics and levels of 
production between IL-10 and IL-6 and IL-8 suggest differ- 
ent immunoregulatory mechanisms involved in their secre- 
tions. The in vivo kinetics of IL-10 during CPB are similar to 
those observed in experimental routine endotoxemia after 
lipopolysaccharide challenge. 4 These kinetics contrast with 
in vitro data showing that IL-10 is produced rather late after 
lipopolysaccharide stimulation of human monocytes 5 and 
suggest that other Cells could be involved in the release of 
IL-10 in vivo. The cellular source(s) of IL-10 and the nature 
of stimuli leading to IL-10 release remain to be determined. 
We concluded that CPB induced an early IL-10 secretion. 
Further studies are required to determine whether this IL-10 
release plays a beneficial role, by reducing the ischemia- 
reperfusion i flammatory esponse, or a detrimental role, by 
decreasing the cellular immune response. 
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Intraoperative use of  end-t idal  carbon dioxide 
tension to assess cardiac output 
To the Editor: 
We read with interest he letter by Feng and Singh 1 on 
the intraoperative monitoring of end-tidal carbon dioxide 
tension (PETCOa) to assess cardiac output during weaning 
from cardiopulmonary b pass (CPB). The authors invited 
comment from those who might have made similar obser- 
vations. 
We have observed for some time that PETCO 2 is a good 
indicator of cardiac performance during weaning from 
CPB. It is our practice to monitor and record PETCO2 
continuously in the prebypass period, adjusting minute 
volume and tidal volume to achieve a PETCO2 of approx- 
imately 4 kPa (30 mm Hg) before bypass. On reinstitution 
Of ventilation and reperfusion of the lungs, we set the 
ventilator to deliver the same minute volume and tidal 
volume as before bypass, in the absence of major meta- 
bolic changes or a major change in dead space, either of 
which we believe occurs rarely, PETCO2 will directly 
reflect carbon dioxide, as explained by Feng and Singh. In 
our experience patients tend to fall into one of three 
groups. The first group comprises those in whom the 
PETCO 2 level is similar to that recorded before CPB. 
These patients generally are able to be weaned readily 
from CPB with minimal additional volume requirement 
and without recourse to inotropic agents or assist devices. 
The second group demonstrates an initial PETCO 2 level 
lower than that recorded before CPB, but this gradually 
returns to the prebypass level. These patients appear to 
commonly require preload augmentation before being 
successfully weaned. Last is a group that has persistent 
low PETCO/levels. These patients will commonly require 
more volume and often require inotropic support or 
occasionally assist devices to be weaned successfully. We 
have a very low threshold for instituting inotropic support 
in patients wh6 have low PETCO2 during weaning from 
CPB despite adequate preload and satisfactory heart rate 
andrhythm. 
At present, because we do not routinely monitor intra- 
operative cardiac output, we have not objectively con- 
firmed the clinical impression that we have described. We 
intend to study the matter in detail later this year. 
Michael J. O'Leary, FRCA 
Colin Ferguson, FRCA 
Departments ofAnaesthesia and Intensive Care 
St. Bartholomew's Hospital 
West Smithfield 
London EC1A 7BE, United Kingdom 
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